These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 7516473)

  • 41. Interferon gamma-induced transcription of the high-affinity Fc receptor for IgG requires assembly of a complex that includes the 91-kDa subunit of transcription factor ISGF3.
    Pearse RN; Feinman R; Shuai K; Darnell JE; Ravetch JV
    Proc Natl Acad Sci U S A; 1993 May; 90(9):4314-8. PubMed ID: 8483949
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Papillomavirus type 16 oncogenes downregulate expression of interferon-responsive genes and upregulate proliferation-associated and NF-kappaB-responsive genes in cervical keratinocytes.
    Nees M; Geoghegan JM; Hyman T; Frank S; Miller L; Woodworth CD
    J Virol; 2001 May; 75(9):4283-96. PubMed ID: 11287578
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Novel regulation of keratin gene expression by thyroid hormone and retinoid receptors.
    Tomić-Canić M; Day D; Samuels HH; Freedberg IM; Blumenberg M
    J Biol Chem; 1996 Jan; 271(3):1416-23. PubMed ID: 8576132
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The IFN-gamma-dependent suppressor of cytokine signaling 1 promoter activity is positively regulated by IFN regulatory factor-1 and Sp1 but repressed by growth factor independence-1b and Krüppel-like factor-4, and it is dysregulated in psoriatic keratinocytes.
    Madonna S; Scarponi C; Sestito R; Pallotta S; Cavani A; Albanesi C
    J Immunol; 2010 Aug; 185(4):2467-81. PubMed ID: 20644166
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CD2 stimulation leads to the delayed and prolonged activation of STAT1 in T cells but not NK cells.
    Mahajan S; Gollob JA; Ritz J; Frank DA
    Exp Hematol; 2001 Feb; 29(2):209-20. PubMed ID: 11166460
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analysis of SOCS-3 promoter responses to interferon gamma.
    Gatto L; Berlato C; Poli V; Tininini S; Kinjyo I; Yoshimura A; Cassatella MA; Bazzoni F
    J Biol Chem; 2004 Apr; 279(14):13746-54. PubMed ID: 14742442
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Stat1 depends on transcriptional synergy with Sp1.
    Look DC; Pelletier MR; Tidwell RM; Roswit WT; Holtzman MJ
    J Biol Chem; 1995 Dec; 270(51):30264-7. PubMed ID: 8530443
    [TBL] [Abstract][Full Text] [Related]  

  • 48. IFN-gamma regulation of class II transactivator promoter IV in macrophages and microglia: involvement of the suppressors of cytokine signaling-1 protein.
    O'Keefe GM; Nguyen VT; Ping Tang LL; Benveniste EN
    J Immunol; 2001 Feb; 166(4):2260-9. PubMed ID: 11160280
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Response of keratinocytes from normal and psoriatic epidermis to interferon-gamma differs in the expression of zinc-alpha(2)-glycoprotein and cathepsin D.
    Chen SH; Arany I; Apisarnthanarax N; Rajaraman S; Tyring SK; Horikoshi T; Brysk H; Brysk MM
    FASEB J; 2000 Mar; 14(3):565-71. PubMed ID: 10698972
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cooperation of STAT-1 and IRF-1 in interferon-gamma-induced transcription of the gp91(phox) gene.
    Kumatori A; Yang D; Suzuki S; Nakamura M
    J Biol Chem; 2002 Mar; 277(11):9103-11. PubMed ID: 11781315
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Biomolecular interaction analysis of IFN gamma-induced signaling events in whole-cell lysates: prevalence of latent STAT1 in high-molecular weight complexes.
    Lackmann M; Harpur AG; Oates AC; Mann RJ; Gabriel A; Meutermans W; Alewood PF; Kerr IM; Stark GR; Wilks AF
    Growth Factors; 1998; 16(1):39-51. PubMed ID: 9777369
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21 WAF1/CIP1 mediated by STAT1.
    Chin YE; Kitagawa M; Su WC; You ZH; Iwamoto Y; Fu XY
    Science; 1996 May; 272(5262):719-22. PubMed ID: 8614832
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Loss of interferon-gamma inducibility of TAP1 and LMP2 in a renal cell carcinoma cell line.
    Dovhey SE; Ghosh NS; Wright KL
    Cancer Res; 2000 Oct; 60(20):5789-96. PubMed ID: 11059775
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interferon-gamma-induced regulation of peroxisome proliferator-activated receptor gamma and STATs in adipocytes.
    Waite KJ; Floyd ZE; Arbour-Reily P; Stephens JM
    J Biol Chem; 2001 Mar; 276(10):7062-8. PubMed ID: 11106650
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression regulation and genomic organization of human polynucleotide phosphorylase, hPNPase(old-35), a Type I interferon inducible early response gene.
    Leszczyniecka M; Su ZZ; Kang DC; Sarkar D; Fisher PB
    Gene; 2003 Oct; 316():143-56. PubMed ID: 14563561
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Growth hormone rapidly activates rat serine protease inhibitor 2.1 gene transcription and induces a DNA-binding activity distinct from those of Stat1, -3, and -4.
    Thomas MJ; Gronowski AM; Berry SA; Bergad PL; Rotwein P
    Mol Cell Biol; 1995 Jan; 15(1):12-8. PubMed ID: 7528325
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Inhibition of interferon gamma signaling by the short chain fatty acid butyrate.
    Klampfer L; Huang J; Sasazuki T; Shirasawa S; Augenlicht L
    Mol Cancer Res; 2003 Sep; 1(11):855-62. PubMed ID: 14517348
    [TBL] [Abstract][Full Text] [Related]  

  • 58. STAT1 is required for IFN-gamma-mediated gut-enriched Krüppel-like factor expression.
    Chen ZY; Shie JL; Tseng CC
    Exp Cell Res; 2002 Nov; 281(1):19-27. PubMed ID: 12441126
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cloning and functional characterization of the 5'-regulatory region of the human CD86 gene.
    Li J; Colovai AI; Cortesini R; Suciu-Foca N
    Hum Immunol; 2000 May; 61(5):486-98. PubMed ID: 10773351
    [TBL] [Abstract][Full Text] [Related]  

  • 60. In psoriasis lesional skin the type I interferon signaling pathway is activated, whereas interferon-alpha sensitivity is unaltered.
    van der Fits L; van der Wel LI; Laman JD; Prens EP; Verschuren MC
    J Invest Dermatol; 2004 Jan; 122(1):51-60. PubMed ID: 14962089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.